We are monitoring the impact of COVID-19 on APAC Clinical Nutrition Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 730
Share on
Share on

Asia Pacific Clinical Nutrition Market Research Report - By Product Type, Therapeutic Areas, Ingredients Type and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 730
Pages: 141

APAC Clinical Nutrition Market Size (2021 to 2026)

The size of the Clinical Nutrition Market in the Asia Pacific was worth USD 3.82 Billion in 2021 and is estimated to be growing at a CAGR of 7.17% to reach USD 5.39 billion by 2026. The Asia-pacific clinical nutritional market is mainly driven by increasing awareness of such products among ordinary people.

Vitamins, Amino acids, minerals, carbohydrates, and proteins are some of the essential nutrients required in the diet. In addition, various diseases such as diabetes, cancer, GI diseases, kidney and cardiovascular diseases can be treated or controlled using clinical nutritional products. These are available in liquids, powders, tablets, injections, or foods such as yogurt and Probiotics.

The high birth rate, growing geriatric population, the surge in the number of victims of malnutrition getting treatment, a high number of premature births, the rising prevalence of lifestyle-associated diseases, and the increasing incidence of cancer and central nervous system diseases are some of the key factors driving the clinical nutrition market in the Asia-pacific region. Additionally, factors such as the rising frequency of metabolic illnesses, high healthcare spending, and the expansion of the middle class in emerging nations are estimated to accelerate the growth rate of the clinical nutrition industry forward in the APAC region.

 Dietary therapy is required for normal growth and development and to prevent acute and long-term impacts of the disorder. Failure to follow a specific nutritional plan can cause complications and even death in those with metabolic illnesses. Patients with genetic metabolic disorders will require nutritional therapy for the rest of their lives. Patients with a range of inborn metabolic disorders require a multidisciplinary approach involving nutritional and medicinal treatment. The bulk of metabolic illnesses are caused by the body’s inability to produce non-essential compounds such as vitamins, amino acids, and several substances involved in metabolic pathways. The majority of these problems can be resolved with just one or two vitamin supplements. The aforementioned factors are expected to contribute to the market’s growth during the forecast period.

However, the growth rate of the APAC clinical nutrition market is expected to be hampered by the lack of understanding about clinical medical nutrition and strict regulations during the forecast period. In addition, the diverse nature of government coverage/reimbursement between nations is one factor that could limit market expansion.

Impact of COVID-19 on the APAC clinical nutrition market:

The COVID-19 pandemic is likely to impact the APAC clinical nutrition market significantly, as the need for nutritional management continues to rise, particularly among youngsters and the elderly.

This research report on the APAC clinical nutrition market has been segmented and sub-segmented into the following categories:

By Product Type: 

  • Oral Nutrition
  • Enteral Nutrition
  • Parenteral Nutrition

By Therapeutic Areas: 

  • Malabsorption
  • Diarrhea
  • Cancer
  • Food Allergies
  • Maldigestion
  • Diabetes
  • Short-Bowel Syndrome
  • Acute Lung Injury
  • Acute Respiratory Distress

By Ingredients Type: 

  • Vitamins
  • Minerals
  • Carbohydrates
  • Amino Acids

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, in the Asia Pacific, China and India are expected to emerge fast in the forecast period due to the rise in population in the following countries.

India is the largest and fastest-growing market in the Asia Pacific region. According to a UNICEF report, 69% of deaths of children are caused by malnutrition in India. This country has initiated numerous awareness campaigns to increase people’s knowledge levels over clinical nutrition. For Instance, The Indian Association of Parental & Enteral Nutrition organization promotes clinical research, advanced education, and clinical quality and care control. The organization mainly focuses on improvement in the nutritional care of people at the stage of malnutrition or health-related diseases. Clinical Nutritionists create effective plans aimed at the nourishment of the body, strengthening of the immune system.

China is the second-largest market in the Asia Pacific clinical nutritional market and the most lucrative market. Increasing the economy partly responsible for growing parental nutrition coupled with excellent infrastructure and R &D facilities facilitates the Chinese clinical nutrition market during the forecast period.

The total population of Japan was calculated at 126.0 million in 2019. The National Nutrition Survey in Japan happens every year, and this survey aims to provide information on the food and nutrition intake of the Japanese people. In Japan, Clinical nutrition and related diet are considered an essential part of the lifestyle, which is estimated to favor the market in this country.

KEY MARKET PLAYERS:

A few of the promising companies operating in the APAC Clinical Nutrition Market profiled in this report are Nestle Nutrition, Abbott Laboratories Inc., Gentiva Health Services Inc., Mead Johnson & Company, Kendall, Ajinomoto Co. Inc., Hospira Inc., Hero Nutritionals Inc., Lonza Ltd, Baxter International Inc., B. Braun Melsungen AG, H. J. Heinz Company, American Home Patient Inc. and Fresenius Kabi.

1. Introduction                             

              1.1 Market Definition                  

              1.2 Study Deliverables                

              1.3 Base Currency, Base Year and Forecast Periods                       

              1.4 General Study Assumptions              

2. Research Methodology                                       

              2.1 Introduction                           

              2.2 Research Phases                    

                             2.2.1 Secondary Research          

                             2.2.2 Primary Research

                             2.2.3 Econometric Modelling     

                             2.2.4 Expert Validation 

              2.3 Analysis Design                      

              2.4 Study Timeline                       

3. Overview                                   

              3.1 Executive Summary              

              3.2 Key Inferences                       

              3.3 New Developments              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                

              4.1 Market Drivers                       

              4.2 Market Restraints                  

              4.3 Key Challenges                       

              4.4 Current Opportunities in the Market                           

5. Market Segmentation                                          

              5.1 By Route of Administration               

                             5.1.1 Oral Nutrition       

                             5.1.2 Enteral Nutrition  

                             5.1.3 Parenteral Nutrition          

              5.2 By Therapeutic Area                            

                             5.2.1 Malabsorption     

                             5.2.2 Diarrhoea

                             5.2.3 Cancer     

                             5.2.4 Food Allergies       

                             5.2.5 Maldigestion         

                             5.2.6 Diabetes  

                             5.2.7 Short-Bowel Syndrome     

                             5.2.8 Acute Lung Injury

                             5.2.9 Acute Respiratory Distress             

              5.3 By Ingredients Type              

                             5.3.1 Vitamins  

                             5.3.2 Minerals  

                             5.3.3 Carbohydrates     

                             5.3.4 Amino Acids          

6. Geographical Analysis                                         

              6.3 Asia-Pacific               

                             6.1 Introduction             

                             6.2 China           

                             6.3 India            

                             6.4 Japan           

                             6.5 South Korea             

                             6.6 Australia     

7. Strategic Analysis                                   

              7.1 PESTLE analysis                      

                             7.1.1 Political    

                             7.1.2 Economic

                             7.1.3 Social       

                             7.1.4 Technological       

                             7.1.5 Legal         

                             7.1.6 Environmental     

              7.2 Porter’s Five analysis                          

                             7.2.1 Bargaining Power of Suppliers       

                             7.2.2 Bargaining Power of Consumers   

                             7.2.3 Threat of New Entrants    

                             7.2.4 Threat of Substitute Products and Services             

                             7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                    

              8.1 Nestle Nutrition                     

                             8.1.1 Overview 

                             8.1.2 Product Analysis  

                             8.1.3 Strategic Evaluation and Operations          

                             8.1.4 Financial analysis 

                             8.1.5 Legal issues           

                             8.1.6 Recent Developments       

                             8.1.7 SWOT analysis      

                             8.1.8 Analyst View         

              8.2 Abbott Laboratories Inc.                    

              8.3 Gentiva Health Services Inc.              

              8.4 Mead Johnson & Company               

              8.5 Kendall                      

              8.6 Ajinomoto Co. Inc.                

              8.7 Hospira Inc.              

              8.8 Hero Nutritionals Inc.                         

              8.9 Lonza Ltd                  

              8.10 Baxter International Inc.                  

              8.11 B. Braun Melsungen AG                   

              8.12 H. J. Heinz Company                         

9. Competitive Landscape                                       

              9.1 Market share analysis                         

              9.2 Merger and Acquisition Analysis                    

              9.3 Agreements, collaborations and Joint Ventures                      

              9.4 New Product Launches                       

10. Expert Opinions                                   

              10.1 Market Outlook                   

              10.2 Investment Opportunities               

Appendix                                       

              a) List of Tables              

              b) List of Figures                           

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Clinical Nutrition Market, By Region, From 2021 to 2026 (USD Million)
  2. Asia-Pacific Clinical Nutrition Market, By Route of Administration, From 2021 to 2026 (USD Million)
  3. Asia-Pacific Oral Nutrition Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia-Pacific Enteral Nutrition Market, By Region, From 2021 to 2026 (USD Million)
  5. Asia-Pacific Parenteral Nutrition Market, By Region, From 2021 to 2026 (USD Million)
  6. Asia-Pacific Clinical Nutrition Market, By Therapeutic Area, From 2021 to 2026 (USD Million)
  7. Asia-Pacific Malabsorption Market, By Region, From 2021 to 2026 (USD Million)
  8. Asia-Pacific Diarrhea Market, By Region, From 2021 to 2026 (USD Million)
  9. Asia-Pacific Cancer Market, By Region, From 2021 to 2026 (USD Million)
  10. Asia-Pacific Food Allergies Market, By Region, From 2021 to 2026 (USD Million)
  11. Asia-Pacific Maldigestion Market, By Region, From 2021 to 2026 (USD Million)
  12. Asia-Pacific Diabetes Market, By Region, From 2021 to 2026 (USD Million)
  13. Asia-Pacific Short-Bowel Syndrome Market, By Region, From 2021 to 2026 (USD Million)
  14. Asia-Pacific Acute Lung Injury Market, By Region, From 2021 to 2026 (USD Million)
  15. Asia-Pacific Acute Respiratoty Diseases Market, By Region, From 2021 to 2026 (USD Million)
  16. Asia-Pacific Clinical Nutrition Market, By Ingridients Type, From 2021 to 2026 (USD Million)
  17. Asia-Pacific Vitamins Market, By Region, From 2021 to 2026 (USD Million)
  18. Asia-Pacific Minerals Market, By Region, From 2021 to 2026 (USD Million)
  19. Asia-Pacific Carbohydrates Market, By Region, From 2021 to 2026 (USD Million)
  20. Asia-Pacific Amino Acids Market, By Region, From 2021 to 2026 (USD Million)
  21. China Clinical Nutrition Market, By Route of Administration, From 2021 to 2026 (USD Million)
  22. China Clinical Nutrition Market, By Therapeutic Area, From 2021 to 2026 (USD Million)
  23. China Clinical Nutrition Market, By Ingridients Type, From 2021 to 2026 (USD Million)
  24. India Clinical Nutrition Market, By Route of Administration, From 2021 to 2026 (USD Million)
  25. India Clinical Nutrition Market, By Therapeutic Area, From 2021 to 2026 (USD Million)
  26. India Clinical Nutrition Market, By Ingridients Type, From 2021 to 2026 (USD Million)
  27. Japan Clinical Nutrition Market, By Route of Administration, From 2021 to 2026 (USD Million)
  28. Japan Clinical Nutrition Market, By Therapeutic Area, From 2021 to 2026 (USD Million)
  29. Japan Clinical Nutrition Market, By Ingridients Type, From 2021 to 2026 (USD Million)
  30. South Korea Clinical Nutrition Market, By Route of Administration, From 2021 to 2026 (USD Million)
  31. South Korea Clinical Nutrition Market, By Therapeutic Area, From 2021 to 2026 (USD Million)
  32. South Korea Clinical Nutrition Market, By Ingridients Type, From 2021 to 2026 (USD Million)
  33. Australia Clinical Nutrition Market, By Route of Administration, From 2021 to 2026 (USD Million)
  34. Australia Clinical Nutrition Market, By Therapeutic Area, From 2021 to 2026 (USD Million)
  35. Australia Clinical Nutrition Market, By Ingridients Type, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample